20
September
2019
Do JAK inhibitors have potential in blood and bone marrow cancers?
Read results from Bryter's JAK inhibitor study - a breakthrough treatment for blood and bone marrow cancers.
Read More
Read results from Bryter's JAK inhibitor study - a breakthrough treatment for blood and bone marrow cancers.
Read More8 in 10 UK oncologists agree that the NHS could fall behind the health systems of other developed countries
Read MoreSo, we need stats to test our pipeline drug - but which technique do we use?
Read MoreInternet of [Healthy] Things (IoT) It’s a lot more than clever fridges!
Read MoreRead how diabetes patients and HCPs access information and digital resources
Read MoreCase study: Pharmaceutical client - MS treatment landscaping and decision-making
Read MoreCase study: Oncology future landscaping and positioning
Read More
Previous
